Natamycin
Cat. No.：YN372737
CAS No. ：7681-93-8
| 产品名称: | Natamycin |
| CAS No.: | 7681-93-8 |
| Chemical Name: | (5R,7R,24S)-22R-[(3S-amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-1R,3S,26S-trihydroxy-12R-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8E,14E,16E,18E,20E-pentaene-25R-carboxylic acid |
| Synonyms: | 纳他霉素; Pimaricin |
| 分子量: | 665.73 |
| 分子式: | C₃₃H₄₇NO₁₃ |
| SMILES: | OC([C@H]1[C@@](C[C@H](/C=C/C=C/C=C/C=C/C[C@@H](C)OC2=O)O[C@@](O[C@H](C)[C@@H](O)[C@@H]3N)([H])[C@H]3O)([H])O[C@](O)(C[C@H](C[C@]4([H])[C@@H](/C=C/2)O4)O)C[C@@H]1O)=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Natamycin (Pimaricin) 是由数个链霉菌菌株生产的大环内酯类抗生素，可通过抑制氨基酸和葡萄糖跨质膜的运输来抑制真菌的生长。Natamycin (Pimaricin) 是一种食品防腐剂，在农业中是一种抗真菌剂，被广泛用于真菌性角膜炎的研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Lalitha, P., Vijaykumar, R., Prajna, N.V., et al.In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powderJ. Clin. Microbiol.46(10),3477-3478(2008)
He, C., Zhang, Z., Li, B., et al.Effect of natamycin on Botrytis cinerea and Penicillium expansum—Postharvest pathogens of grape berries and jujube fruitPostharvest Bio. Technol.151,134-141(2019)
Dong, X.H., Gao, W.J., and He, X.P.Antifungal efficacy of natamycin in experimental fusarium solani keratitisInt. J. Ophthalmol.5(2),143-146(2012)
